Dapagliflozin Plus Pioglitazone in T1DM
Dapagliflozin Plus Pioglitazone in T1DM
Active, not recruiting · NCT03878459 · Registry updated 2026-07-29Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Dapagliflozin Plus Pioglitazone in T1DM | Nutritional and Metabolic Diseases, autoimmune disease, diabetes mellitus, endocrine system disorder, glucose metabolism disease, immune system disorder, metabolic disease, type 1 diabetes mellitus | Active, not recruiting | Phase 4 | 2026-07-29 | NCT03878459 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| The University of Texas Health Science Center at San Antonio | 127 |
3 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Dasman Diabetes Institute | Kuwait City | Kuwait | 2 |
| Endocrinology and Diabetes Center, Rambam Medical Center | Haifa | Israel | 1 |
| University Health System Texas Diabetic Institute | San Antonio | United States | 2 |